课题基金 / 基金详情

TYPE 1 FIMBRIAE AND URINARY TRACT INFECTIONS

TYPE 1 FIMBRIAE AND URINARY TRACT INFECTIONS
1 型菌毛和尿路感染
批准号:
6124303
负责人:
DAVID L HASTY
金额:
$18.44万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 2003-11-30

项目摘要

项目成果

DAVID L HASTY的其他基金

相关文献

中文摘要
翻译
描述(改编自申请人的摘要):I型菌毛是 对E.因为它们介导 粘附,刺激粘膜免疫应答并介导相互作用 吞噬细胞。实验研究表明了类型的重要性 1菌毛,但以前的流行病学研究没有发现相关性, 也许是因为fim(1型)基因的实际普遍性 集群FimH粘附素亚基基因的等位基因变体, 显著改变E.大肠杆菌有 最近被发现。它们的分布表明, 表型在泌尿道中提供选择性优势。这 初步的动物研究支持这一假设。的影响 不同fimH等位基因变体的表达对E. 将研究大肠杆菌定殖小鼠泌尿道的能力。等基因E. 将大肠杆菌菌株接种到小鼠膀胱中并感染 通过定量培养和组织病理学研究。我们将确定 小鼠泌尿上皮细胞E.表达 不同的fimH等位基因初步研究使我们把重点放在 移行上皮的不对称单位膜斑块(AUM), 它们的组成蛋白尿斑蛋白体外和体内 粘附和粘附抑制测定(使用尿斑蛋白特异性 抗体),以确认这些分子是否是 1型受体。我们将研究白细胞进入 感染小鼠的泌尿道粘膜。粘附、摄入和 E的呼唤人和小鼠外周血中性粒细胞将大肠杆菌 定量的细胞外和细胞内的氧释放 将测量代谢物。我们将描述的诱导 小鼠尿路感染后尿黏膜细胞因子的变化 重组大肠显示M\H 1型菌毛表型的大肠杆菌菌株 典型的UTI分离株。当基本的反应是 我们将定性或定量地确定 E.表达不同“fimH 等位基因炎症和调节性细胞因子的产生将是 通过ELISA测量和/或消息将通过测量。RT-PCR法蜂窝 细胞因子的来源将通过免疫细胞化学来确定。的 这项研究的长期目标是了解1型糖尿病的作用, 菌毛在UTI发病机制中的作用, 用于治疗或预防。
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Type I fimbriae are important for the urovirulence of E. coli, because they mediate adhesion, stimulate a mucosal immune response and mediate interactions with phagocytes. Experimental studies indicate the importance of type 1 fimbriae, but previous epidemiological studies found no correlation, perhaps because of the virtual ubiquity of the fim (type 1) gene cluster. Allelic variants of the gene for the FimH adhesin subunit that significantly alter the receptor-binding phenotype of E. coli have recently been discovered. Their distribution suggests that certain phenotypes offer a selective advantage in the urinary tract. This hypothesis is supported by preliminary animal studies. The effects of the expression of different fimH allelic variants on the ability of E. coli to colonize the mouse urinary tract will be studied. Isogenic E. coli strains will be inoculated into mouse bladders and infection studied by quantitative cultures and histopathology. We will identify the murine uroepithelial cell receptor(s) for E. coli expressing different fimH alleles. Preliminary studies lead us to focus on the asymmetrical unit membrane plaques (AUMs) of transitional epithelium and their constituent proteins, the uroplakins. In vitro and in vivo adhesion and adhesion inhibition assays (using uroplakin-specific antibodies) will be performed to confirm whether these molecules are the type 1 receptors. We will study the recruitment of leukocytes into the urinary tract mucosa of infected mice. The adhesion, ingestion and calling of E. coli by human and mouse peripheral blood PMN will be quantified and extracellular and intracellular release of oxygen metabolites will be measured. We will characterize the induction of cytokine production in urinary tract mucosa of mice infected with a recombinant E. coli strain exhibiting an M\H type 1 fimbrial phenotype typical of UTI isolates. When the basic responses have been characterized, we will determine whether qualitatively or quantitatively different responses are elicited by E. coli expressing different "fimH alleles. Production of inflammatory and regulatory cytokines will be measured by ELISAs and/or message will be measured by. RT-PCR. Cellular source(s) of cytokines will be determined by immunocytochemistry. The long-term goal of this research is to understand the role of type 1 fimbriae in the pathogenesis of UTIs to eventually enhance procedures for treatment or prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Activation of Macrophages by Lipoteichoic Acid
Activation of Macrophages by Lipoteichoic Acid
TYPE 1 FIMBRIAE AND URINARY TRACT INFECTIONS
TYPE 1 FIMBRIAE AND URINARY TRACT INFECTIONS